Next events
On 0920 2024
On 0920 2024
On 0920 2024
Development of an anti-diabetic kidney disease drug by targeting transcriptional activity of carbohydrate responsive element binding protein (ChREBP)
More than 30% of diabetic patients will eventually develop diabetic kidney disease (DKD), characterized by the presence of elevated urinary albumin…
On 0920 2024
On 0925 2024